SF

Said Francis

General Manager, Individualized Neoantigen Therapy (int) at Moderna Therapeutics

Said Francis has an extensive background in business development and corporate strategy, with experience at companies such as Moderna, Biocartis, Novartis, JP Morgan, and Credit Suisse. Said holds an MBA from Harvard Business School, an M. Eng in Electrical Engineering and Computer Science from Massachusetts Institute of Technology, and a SB in Electrical Engineering and Computer Science from the same institution. Said also completed their French Baccalauréat with a specialty in Physics and Chemistry at Lycee Nahr Ibrahim. Throughout their career, Said has taken on various roles such as General Manager, Chief Business Officer, and Strategy Consultant.

Links

Timeline

  • General Manager, Individualized Neoantigen Therapy (int)

    December 1, 2023 - present

  • Svp, Head Of Business Development & Corporate Strategy

    April, 2019

  • Vp, Head Of Business Development

    October, 2017

  • Senior Director Of Business Development

    March, 2015

  • Director, Corporate Development

    June, 2013

Related people